Another mitochondrial fission inhibitor, P110, abrogating the interaction between DRP1 and FIS1, was shown to inhibit excessive fission as well as to restore mitochondrial function [223]; however, its therapeutic potential is still not demonstrated in the context of AD. Here, FIS1 is linked to Alzheimer disease.